1. Home
  2. AIRG vs PYPD Comparison

AIRG vs PYPD Comparison

Compare AIRG & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Airgain Inc.

AIRG

Airgain Inc.

HOLD

Current Price

$5.22

Market Cap

87.5M

Sector

Technology

ML Signal

HOLD

Logo PolyPid Ltd.

PYPD

PolyPid Ltd.

HOLD

Current Price

$4.99

Market Cap

71.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIRG
PYPD
Founded
1995
2008
Country
United States
Israel
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
87.5M
71.7M
IPO Year
2016
2014

Fundamental Metrics

Financial Performance
Metric
AIRG
PYPD
Price
$5.22
$4.99
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
4
Target Price
$6.25
$12.25
AVG Volume (30 Days)
68.6K
157.6K
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
31.65
N/A
EPS
N/A
N/A
Revenue
$51,779,000.00
N/A
Revenue This Year
$10.31
N/A
Revenue Next Year
$20.71
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.00
$3.06
52 Week High
$7.66
$5.73

Technical Indicators

Market Signals
Indicator
AIRG
PYPD
Relative Strength Index (RSI) 35.80 57.76
Support Level $5.17 $4.15
Resistance Level $5.66 $5.07
Average True Range (ATR) 0.27 0.25
MACD 0.01 0.06
Stochastic Oscillator 9.20 80.45

Price Performance

Historical Comparison
AIRG
PYPD

About AIRG Airgain Inc.

Airgain Incs a provider of advance wireless connectivity solutions. It is focused on delivering high-performance, cost-effective, and energy-efficient wireless solutions that enable rapid market deployment. It mission is to connect the world through integrated, and optimized wireless solutions. Companies' diverse product portfolio serves three primary markets: enterprise, automotive, and consumer. While historically recognized for high-performance radio frequency (RF) components, Airgain is increasingly delivering integrated, system-level connectivity solutions that combine hardware, software, and cloud management. The enterprise market demands reliable wireless access across diverse settings, including smart cities, campuses, stadiums, transportation hubs, utilities, buildings suburbs.

About PYPD PolyPid Ltd.

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

Share on Social Networks: